Cargando…

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

BACKGROUND: CXC chemokine receptor 2 (CXCR2) has been reported to play an important role in the proliferation and invasion of gastric cancer cells. The present study aims to investigate the impact of CXCR2 expression on the overall survival (OS) of gastric cancer patients after radical resection. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhenglin, Liu, Hao, Shen, Zhenbin, Wang, Xuefei, Zhang, Heng, Qin, Jing, Xu, Jiejie, Sun, Yihong, Qin, Xinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619066/ https://www.ncbi.nlm.nih.gov/pubmed/26497045 http://dx.doi.org/10.1186/s12885-015-1793-9

Ejemplares similares

The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis
por: Qiao, Bingbing, et al.
Publicado: (2017)

Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
por: Liu, Hao, et al.
Publicado: (2016)

Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection
por: Wang, Xuefei, et al.
Publicado: (2014)

Mechanism of Cxc Chemokine Ligand 5 (CXCL5)/Cxc Chemokine Receptor 2 (CXCR2) Bio-Axis in Mice with Acute Respiratory Distress Syndrome
por: Wang, Chang-yong, et al.
Publicado: (2019)

Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric Cancer
por: He, Hongyong, et al.
Publicado: (2013)

Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy
por: Liu, Hao, et al.
Publicado: (2016)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
por: Jing, Yanhua, et al.
Publicado: (2022)

Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy
por: Lin, Chao, et al.
Publicado: (2016)

CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
por: Cao, Yifan, et al.
Publicado: (2016)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021)

Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer
por: Wang, Fei, et al.
Publicado: (2021)

The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022)

The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)
por: Caccuri, Francesca, et al.
Publicado: (2019)

Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma
por: Wang, Kun, et al.
Publicado: (2022)

The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma
por: Stofas, Anastasios, et al.
Publicado: (2014)

CXC Chemokine Receptor 7 (CXCR7) Regulates CXCR4 Protein Expression and Capillary Tuft Development in Mouse Kidney
por: Haege, Sammy, et al.
Publicado: (2012)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
por: Huang, Xinxin, et al.
Publicado: (2022)

The Role of CXC Chemokines in Cancer Progression
por: Wu, Tiantian, et al.
Publicado: (2022)

Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia
por: Cao, Tingyong, et al.
Publicado: (2019)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy
por: Liu, Hao, et al.
Publicado: (2017)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
por: Kong, Weina, et al.
Publicado: (2021)

CXC Chemokine CXCL12 and Its Receptor CXCR4 in Tree Shrews (Tupaia belangeri): Structure, Expression and Function
por: Chen, Guiyuan, et al.
Publicado: (2014)

Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy
por: Guo, Fengzhu, et al.
Publicado: (2019)

High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
por: Li, Ruochen, et al.
Publicado: (2016)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
por: Zeng, Qingquan, et al.
Publicado: (2020)

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer
por: Wang, Hongshan, et al.
Publicado: (2016)

A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients
por: LI, HE, et al.
Publicado: (2015)

CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
por: Cabrero-de las Heras, Sara, et al.
Publicado: (2018)

Identification and Profiling of Novel α(1A)-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer
por: Mustafa, Sanam, et al.
Publicado: (2012)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Selected CC and CXC chemokines in children with atopic asthma
por: Machura, Edyta, et al.
Publicado: (2016)

CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
por: Komolafe, Kayode, et al.
Publicado: (2022)

CXC chemokine ligand‐13 promotes metastasis via CXCR5‐dependent signaling pathway in non‐small cell lung cancer
por: Chao, Chia‐Chia, et al.
Publicado: (2021)

B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5
por: Legler, Daniel F., et al.
Publicado: (1998)

Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
por: Li, Yongchao, et al.
Publicado: (2021)

Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma
por: Bian, Dachen, et al.
Publicado: (2022)

The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis
por: Aidoudi, Sallouha, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h387a7b3736v404fahfv6c7hql